Cambridge, Massachusetts-based Orum Therapeutics, a biotech firm, has secured $30 million in Series B financing. The investors were IMM Investment, Smilegate Investment, KTB Network, Stassets Investment, InterVest and KB Investment/Solidus Investment.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: